Health Catalyst (NASDAQ:HCAT) Earns "Neutral" Rating from Cantor Fitzgerald

Key Points

• Health Catalyst's stock has been rated as "neutral" by Cantor Fitzgerald, with a target price of $4.00, indicating a potential upside of 35.14% from its current price.
• The consensus rating for Health Catalyst is currently "Hold," with a price target of $4.73, reflecting mixed opinion among analysts.
• Significant institutional activity has been noted, with several firms increasing their stakes in Health Catalyst, now owned 85% by institutional investors and hedge funds.

Health Catalyst (NASDAQ:HCAT - Get Free Report)'s stock had its "neutral" rating reissued by stock analysts at Cantor Fitzgerald in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $4.00 target price on the stock. Cantor Fitzgerald's price objective points to a potential upside of 35.14% from the company's current price.

HCAT has been the topic of several other research reports. Evercore ISI boosted their price objective on Health Catalyst from $3.00 to $4.00 and gave the company an "in-line" rating in a report on Thursday, August 28th. Stifel Nicolaus dropped their price objective on Health Catalyst from $5.50 to $4.50 and set a "hold" rating on the stock in a report on Friday, August 8th. Piper Sandler cut Health Catalyst from an "overweight" rating to a "neutral" rating and decreased their target price for the stock from $8.00 to $4.00 in a research note on Wednesday, August 27th. Summit Redstone set a $5.00 price target on shares of Health Catalyst in a research note on Friday, August 29th. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Health Catalyst in a report on Saturday, September 27th. Three research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $4.73.

Health Catalyst Price Performance

Health Catalyst stock opened at $2.96 on Tuesday. The company's 50 day simple moving average is $3.19 and its 200-day simple moving average is $3.69. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.83 and a current ratio of 1.83. Health Catalyst has a 1 year low of $2.52 and a 1 year high of $9.24. The company has a market capitalization of $208.31 million, a price-to-earnings ratio of -1.96 and a beta of 1.62.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in HCAT. First Light Asset Management LLC raised its stake in shares of Health Catalyst by 99.1% during the 1st quarter. First Light Asset Management LLC now owns 10,436,807 shares of the company's stock worth $47,279,000 after buying an additional 5,195,686 shares in the last quarter. Nepsis Inc. lifted its holdings in Health Catalyst by 2,072.1% in the first quarter. Nepsis Inc. now owns 2,090,812 shares of the company's stock valued at $9,471,000 after acquiring an additional 1,994,555 shares during the period. Whetstone Capital Advisors LLC acquired a new position in shares of Health Catalyst during the 1st quarter worth $7,724,000. Nuveen LLC purchased a new position in shares of Health Catalyst in the 1st quarter valued at about $2,674,000. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Health Catalyst by 172.6% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 694,361 shares of the company's stock valued at $3,145,000 after purchasing an additional 439,599 shares during the period. 85.00% of the stock is currently owned by institutional investors and hedge funds.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.